Hepatitis C virus replication is directly inhibited by IFN-α in a full-length binary expression system
Open Access
- 7 August 2001
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 98 (17) , 9847-9852
- https://doi.org/10.1073/pnas.171319698
Abstract
Hepatitis C virus (HCV) is a leading cause of chronic hepatitis, cirrhosis, and hepatocellular carcinoma. The absence of culture systems permissive for HCV replication has presented a major bottleneck to antiviral development. We sought to recapitulate the early steps in the life cycle of HCV by means of DNA-based expression of viral genomic sequences. Here we report expression of replicating HCV RNA by using a, to our knowledge, novel binary expression system in which cells were transfected with a T7 polymerase-driven full-length HCV cDNA plasmid containing a cis-acting hepatitis Δ ribozyme to control 3′ cleavage, and infected with vaccinia-T7 polymerase. HCV genomic and replicative strand synthesis, in addition to protein synthesis, was detectable and depended on full-length HCV sequences. Moreover, the system was capable of generating HCV RNA quasispecies, consistent with the action of the low-fidelity HCV NS5B RNA polymerase. IFN-α, but not ribavirin, directly inhibited the viral replicative cycle in these cells, identifying the virus itself and not solely the immune system as a direct target of IFN action. The availability of a cell-based test for viral replication will facilitate screening of inhibitory compounds, analysis of IFN-resistance mechanisms, and analysis of virus–host cell interactions.Keywords
This publication has 26 references indexed in Scilit:
- Efficient Initiation of HCV RNA Replication in Cell CultureScience, 2000
- The Outcome of Acute Hepatitis C Predicted by the Evolution of the Viral QuasispeciesScience, 2000
- Broad-Spectrum Antiviral Activity of the IMP Dehydrogenase Inhibitor VX-497: a Comparison with Ribavirin and Demonstration of Antiviral Additivity with Alpha InterferonAntimicrobial Agents and Chemotherapy, 2000
- Mutations in nonstructural protein 5A gene and response to interferon in hepatitis C virus genotype 2 infectionHepatology, 1999
- The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994New England Journal of Medicine, 1999
- Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell LineScience, 1999
- Heterogeneous Nuclear Ribonucleoprotein I (hnRNP-I/PTB) Selectively Binds the Conserved 3′ Terminus of Hepatitis C Viral RNABiochemical and Biophysical Research Communications, 1999
- Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: A multicenter trialHepatology, 1997
- Lack of Protective Immunity Against Reinfection with Hepatitis C VirusScience, 1992
- Molecular Mechanisms of Action of RibavirinClinical Infectious Diseases, 1990